chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest tightness starting ~4 hours post-injection accompanied by increased HR and mild pain/pressure on deep inspiration.  Occurred intermittently for the rest of the evening (1/25/21) and into the next day (1/26/21).  Mostly located along the left side of the sternum and at the base of the sternum.  In the following 9 days (to today (2/3/21))  symptoms persisted, occurring about once a day and gradually becoming more mild.   On day 4 post-injection (1/29/21) enlarged and tender lymph nodes were noticed in the left axillary region and supraclavicular region.  They grew in size and increased in tenderness to mild pain until 2/1/21 and have since been steadily decreasing in size and in tenderness although still noticeable in size and uncomfortable today. Symptoms did not prevent me from doing my normal exercise or school activities.  No treatment or medications were taken.
Pharmacist injected covid booster in left arm closer to shoulder blade The day after the vaccine I felt fever body aches (a typical symptom after vaccine) 11/04/2021 felt better 11/07/2021 11/10/2021 felt sore arm still red in injection spot  11/11/2021 felt bruising in injection area immediately after felt numbness and tingling sensation from shoulder to arm
This spontaneous report was received from a registered nurse and refers to an unspecified patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 03-MAY-2017, the patient was vaccinated with a dose of improperly stored VARIVAX lot # M032493 with expiration date on 06-JUL-2018 (dose and route of administration were not reported). The vaccine underwent a temperature excursion of 13 degrees Fahrenheit for 9 hours. Digital data logger was used to record the excursion. The vaccine underwent previous temperature excursion of 7 degrees Fahrenheit for 17 hours and 30 minutes. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1706USA002688:
Pt developed swelling of right jaw, pain in right ear and neck, wheezing and fever. She denies any rash.
Headache, fever, chills, fatigue, body aches that started at 11pm the day of vaccine and subsided  around 5pm the next day.
vaccination site pain; This case was reported by a physician via sales rep and described the occurrence of injection site pain in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient age was over 70 years old. The age at vaccination was not reported. After vaccination with 1st dose, the patient experienced injection site pain for 2 days. The reporter agree to follow up. For the tollerence of 2nd dose, refere case US2019AMR136243.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with the third dose of GARDASIL. The patient experienced tingling and numbness at midnight the same day of the vaccination. The patient went to the emergency room and was "discharged" several hours later. Unspecified tests were performed at the emergency room (results not reported). The patient sought unspecified medical attention by phone call. The patient did not have any problems with the first and second doses of GARDASIL. On an unknown date the patient recovered from tingling and numbness. Additional information has been requested.
Information has been received from a Licensed Practical Nurse (L.P.N) referring to multiple unspecified patients of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On multiple unspecified dates, the patients were vaccinated with improperly stored GARDASIL (dose, lot # and route unspecified). Information regarding concomitant medications was not reported. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Initial report was received from another manufacturer, who received the case from a health care professional, under manufacturer report number 2012081072 on 16 April 2012. A two-month-old female patient, with an unknown medical history, had received an injection of PENTACEL, sanofi pasteur Ltd., lot number C3928AA, PREVNAR 13, Pfizer, lot number F24141 and ROTATEQ, Merck, lot number 1240AA on 26 March 2012 (route, site and dose not reported). On 26 March 2012, the patient experienced extra puffiness, was crying excessively and had a fever. The patient's rectal temperature on 26 March 2012 was 100.4 and on 27 March 2012 the patient's rectal temperature was between 100.5 to 101. The patient was hospitalized on 27 March 2012 and was not discharged at the time of the report. The patient had blood work on an unknown date in March of 2012 while being hospitalized, however the results were unknown. The patient was recovering from the events at the time of the report. It was unknown if the patient took any concomitant medications. No further information was available at the time of the report. The patient's outcome was recovering (not recovered). Documents held by sender: None.
101 Fever; Chills; Aches; Swollen lymph node under right arm; Tender lymph node under right arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the right arm on 09Apr2021 at 13:45(at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, migraine, polycystic ovarian syndrome (PCOS), mitral valve prolapse and allergies (unspecified). The patient had allergy to penicillin and tree nuts. The patient previously took cefaclor (CECLOR) and cefalexin (KEFLEX) and experienced drug allergy. Concomitant medications included mometasone furoate (ASMANEX), fexofenadine hydrochloride (ALLEGRA), bisoprolol (MANUFACTURER UNKNOWN), fluoxetine (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN) all for unspecified indications from on unknown date and unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 04:00 the patient experienced fever 101 (unspecified units), chills, swollen and tender lymph node under right arm and aches. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment at home pain and fever relief. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event fever 101 (unspecified units), chills, swollen and tender lymph node under right arm and aches was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a 66 year old female who was approximately 10-AUG-2007, was vaccinated with Zostavax (Oka/Merck). The physician reported that after vaccination with Zostavax (specific date unspecified), the patient had a local reaction at the injection site. The injection site reaction was painful, red and swollen. The reaction never completely resolved and now had become a complex mass 3.4 x 3.9 by 3.6 cm in diameter at the injection site. The mass was diagnosed as a soft tissue complex cystic mass on 14-SEP-2007 by ultrasound. The physician indicated that as of 14-SEP-2007 it was about 5 weeks from the vaccination with the Zostavax. The patient's soft tissue complex cystic mass persisted. Additional information has been requested.
Some dizziness after 1st vaccine for couple days about 10 days after. Extreme dizziness after 2nd vaccine, also about 10 days after.  Still going on after 2 days.
after recv vax pt exp 2 sore arms, fever, vomited all night, stomach cramps, headache, in bed 5 days
Moderna Covid vaccine - error report.   Moderna vaccine was administered to patient under age 18 years.  Patient was 16 years and 5 months old at time of initial vaccination.  Second vaccine was administered 28 days later (3/31/21) using Moderna lot  021B21A.  Age under 18 years was recognized by providers after administration of second dose.  Patient has not reported an adverse event.
2-19-21 - Upon receiving shoot, experienced pain, slight redness, and itching in the injection site.  After about a week all subsided. 3-2-21 -  I am now experiencing an increased amount of itching at the injection site and the redness at the injection site has grown to about  2 inches in diameter.  The injection site is warm to touch.
Comments: R anterior thigh with raised somewhat papular area. Blanches to palpation. Palpation does not seem to cause pain. 5 cm at the largest diameter. Treated w/ mupirocin 2% topical ointment and recommended BENADRYL cream.
Client called on 10-25-21 to report that her should remains sore. She states that she feels the injection was given too high. When at rest, her arm does not hurt. When she moves it, especially backward or arms above the head, there is an achy pain. No shooting pain. Client states this has never happened to her with injections before and it has not dissipated over time.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 71-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Mar2023 at 12:00 as dose 5 (booster), single (Lot number: GJ6743) at the age of 71 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Cardiac bypass surgery 14 years ago" (unspecified if ongoing). Concomitant medication(s) included: TAMSULOSIN; ROSUVASTATIN; METOPROLOL; OMEPRAZOLE. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 4; MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: ASTHENIA (non-serious) with onset 28Mar2023 at 14:00, outcome "not recovered", described as "General weakness"; PAIN (non-serious) with onset 28Mar2023 at 14:00, outcome "not recovered", described as "body aches"; PYREXIA (non-serious) with onset 28Mar2023 at 14:00, outcome "not recovered", described as "fever (99-100.5)"; OROPHARYNGEAL PAIN (non-serious) with onset 28Mar2023 at 14:00, outcome "not recovered", described as "minor sore throat". The events "general weakness", "minor sore throat", "fever (99-100.5)" and "body aches" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of asthenia, oropharyngeal pain, pyrexia, pain. Additional information: The events general weakness, minor sore throat, body aches and fever (99-100.5) has persisted for 3 days (at the time of reporting). The patient's body temperature in Mar2023 was 99-100.5. Treatment for the events asthenia, oropharyngeal pain, pyrexia, and pain included acetaminophen (TYLENOL). Prior to the vaccination, the patient was not diagnosed COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any known allergies.
One day after receiving immunizations, left thigh noted to be red and swollen. Itchy, pt scratching at it. No fever. Not tender. Walks normally. On exam 8 X 13 cm area of induration and erythema surrounding injection site. No warmth, tenderness, or discharge. Treated symptomatically.
Pt had hives and swelling of tongue. She began to report shortness of breath and tightness in her chest. She became lethargic and diaphoretic.
Stated often has panic attacks when receives shots or has IVs placed. Stated after vaccination, tongue started to feel bigger and to itch at the back, throat also started to feel tight. Monitored by EMTs in parking lot. Given oral Benadyl. Was not transported to hospital. Husband came to pick her up.  Stated a few hours later felt pressure in windpipe at level of clavicles & had difficulty breathing.  Stated sleep the rest of the day. Denies HA, fever, or chills. Stated throat felt better the next day though still feels pressure at base of throat. Also complaining of occasional "brain zap" (zing in brain that then causes eye to twitch). States that since tongue started feeling big she has had trouble talking--words coming out funny. States that is still happening.
injection site soreness; diarhea; chills; fever; headache; felt sick; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 83-year-old female patient who received Herpes zoster (Shingrix) (batch number M95T2, expiry date 29th October 2021) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (received 1st dose on 14th May 2019 and experienced injection site soreness, refer case US2019144922).   On 31st July 2019, the patient received the 2nd dose of Shingrix .5 ml. On 1st August 2019, 1 days after receiving Shingrix, the patient experienced injection site pain, diarrhea, chills, fever, headache and feeling unwell. Rechallenge with Shingrix was positive. On 4th August 2019, the outcome of the injection site pain, diarrhea, chills, fever, headache and feeling unwell were recovered/resolved.   It was unknown if the reporter considered the injection site pain, diarrhea, chills, fever, headache and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on right arm. The patient experienced injection site soreness, diarrhea, chills, fever, headache, and felt sick. The reporter consented to follow up.
Pt had vaccination on 7/15/13. Pt reported redness at injection site with warmness to skin. Pt reported to take BENADRYL on f/u with MD
Information has been received from a physician concerning a 11 month old male patient who on 25-FEB-2010 was vaccinated with the first 0.5 mL dose of VARIVAX (Merck). Concomitant was vaccinated with MMR II (MSD) and VAQTA (inactive) (manufacturer unknown) on same day but on different arm. The physician reported that on 25-FEB-2010, the patient developed 1 cm hives at the injection sire where VARIVAX (Merck) was administered. At the time of the report, the patient was recovering. Additional information has been requested.
One day post vax, the pt developed a skin knot at the injection site. No further information was available at the date of this report.
Information has been received from an office manager concerning an approximately 16 year old female patient who on 27-JUN-1995 was vaccinated with the first pediatric dose of Hep B (manufacturer unknown) (lot #, expire date and route not reported), 5 mcg/ 0.5 ml. On 31-JUL-1995, the patient was vaccinated with the second pediatric dose of Hep B (manufacturer unknown) (lot #, expire date and route not reported), 5 mcg/ 0.5 ml and on 29-NOV-1995, the patient was vaccinated with the third pediatric dose of Hep B (manufacturer unknown) (lot #, expire date and route not reported), 5 mcg/ 0.5 ml. The office manager stated that the patient was given 3 doses of Hep B (manufacturer unknown) and on an unspecified date, the patient still had negative titers for hepatitis B. It was unknown if the patient sought medical attention. At the time of the report, patient's outcome was unknown. Follow up information has been received from a physician concerning the female student. On an unspecified date, the patient's hepatitis B titers showed non immune 0.56. The patient received the third dose of Hep B (manufacturer unknown) when she was 9 months old. It was reported that the vaccine doses was not given at that office. The patient did not seek medical attention. At the time of the report, the patient recovered on an unspecified date. No further information is available.
I have had 2 periods since getting the covid vaccine, both have been abnormally heavy. I have never experienced such heavy periods even in my early 20s. The blood seems to be gushing out and thin.
Patient received KINRIX / Varicella in right arm, MMR in left arm, FLUMIST nasally. Right arm presented next day with redness, swelling, warmth. Referred to a doctor.
terrible headache; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 68-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (at the age of 68 years old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included anticoagulant therapy (The first time he got the shot he has underlying conditions, including blood thinners, he is on 2 blood thinners. he had to wait 45 minutes after the first shot). On an unspecified date the patient experienced terrible headache. He has to be honest its kind of a disgraceful arrangement, as far as people giving the shot. The quality of the people. Giving it at a ball field is not exactly conducive to feeling confident about it. When you watch tv, they get a shot and they are in a chair, but there they had a nurse completely unprotected and these are people outside and they are massive amounts of shots and he doesn't know if it is getting applied right. It is just not a good feeling of confidence; it was poorly organized. The first time he got the shot he has underlying conditions, including blood thinners, he is on 2 blood thinners. he had to wait 45 minutes after the first shot. The outcome of the event was unknown. He does not think he had any thing else other than the terrible headache that was his only first shot incidents. He clarifies he had a headache after both the first and the second shot, he has a bad headache right now.  Follow-up attempts are completed. No further information is expected.
c/o redness, itching, swollen lymph node, under arms swelling. Started several days after shot and ongoing. Also slight fever (resolved 02/24/2003)
Received flu vaccine 9/11 ~2:30pm. ~7pm began having sensation of rapid HR- recorded by Fitbit 107 BPM. Was sitting calmly studying w/o stress or anxiety that could explain the tachy. Also had chest tightness/diff breathing which I would assoc with asthma, but not comfortable using albuterol inhaler to exacerbate uncomfortable rapid HR. ~8pm myalgias and general malaise, took 1/2 dose acetaminophen. Aches made it uncomfortable to study, vague HA, headed for bed. Myalgias progressed to cramping and weakness with assoc. nausea. 9pm chills and fever of 100.5, second 1/2 dose of acetaminophen. Severe pain/cramping/weakness in cervical, thoracic, lumbar regions, unable to relieve with position changes in bed. Nausea continued, no vom. Alternating chills/diaphoresis. Continued until 12a. Mostly resolved by 5a, able to work 9/12.
Chills, fever, hardening of muscle, headache, joint pain, muscle pain, body aches, cold sweats, red splotches at injection site, inability to move left arm without severe pain, fatigue.
Patient was given an undiluted dose of the Covid 19 vaccine on Sunday, June 6th at 10:28 AM.  Patient was called the same day, and a few days after, with no adverse effects to report.
Patient was admitted to the hospital with COVID symptoms and was treated with typical COVID medications. Patient was discharged.
Still tired the next day; Photophobia; Felt as if she had the COVID-19 virus all over again; Nausea; Muscle ache; Headaches, sore head; Fever of 100.4 then 101.4; Fatigue; This spontaneous case was reported by a nurse and describes the occurrence of PHOTOPHOBIA (photophobia), SUSPECTED COVID-19 (Felt as if she had the COVID-19 virus all over again), NAUSEA (Nausea), MYALGIA (Muscle ache) and HEADACHE (Headaches, sore head) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 11-Jan-2021 to 26-Jan-2021 and Cardiac ablation (ablation in 2016) in 2016. Concurrent medical conditions included Thyroid disorder (Past Medical History includes thyroid since 1993 or 1994) and Atrial fibrillation since 2015. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PHOTOPHOBIA (photophobia), SUSPECTED COVID-19 (Felt as if she had the COVID-19 virus all over again), NAUSEA (Nausea), MYALGIA (Muscle ache), HEADACHE (Headaches, sore head), PYREXIA (Fever of 100.4 then 101.4) and FATIGUE (Fatigue). On 25-Feb-2021, the patient experienced FATIGUE (Still tired the next day). On 24-Feb-2021, PHOTOPHOBIA (photophobia), NAUSEA (Nausea), MYALGIA (Muscle ache), HEADACHE (Headaches, sore head) and PYREXIA (Fever of 100.4 then 101.4) had resolved, SUSPECTED COVID-19 (Felt as if she had the COVID-19 virus all over again) outcome was unknown. At the time of the report, FATIGUE (Fatigue) outcome was unknown and FATIGUE (Still tired the next day) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Body temperature: 103 (Inconclusive) Temperature was 103 degrees Fahrenheit. On 24-Feb-2021, Body temperature: 100.4 (Inconclusive) Fever of 100.4 and 101.4 (Inconclusive) Fever of 101.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product also included thyroid medications.  Treatment information was not provided.
Took picture of reaction, then put alcohol on injection site for three days.  Physically sick for two days after injection.
Pt received a previous dose of Pfizer CVOID-19 vaccine on 2/23/2021. RN administered  Moderna  COVID-19 vaccine 03/17/2021 which is day 23 after first vaccine. Patient was notified at clinic and observed for 30 min. Pt denied any adverse reaction. As per clinic staff on site, pt did not have any signs of an adverse reaction. Medical director for the clinic was consulted. As per Medical Director, recommendation is not to revaccinate and consider the series to be complete. As per Medical Director patient signed up for V-Safe and will be follow-up daily for 7 days.
I got the 2nd dose, I went and sat down my heart was racing and I was breathing funny. The side were I got the shot my muscles felt like it was moving and my face started to droop and was swelling. The rushed me to the er and they gave me an cocktail for my reaction and they said that I passed out. It was like I went to sleep and and woke up with a disability. I have muscle spams in my face, I could feed myself my daughter had to feed me. They told me that it was bells palsy. they gave me pretonze and stomach meds to treat it. They told me they wouldn't take my case since the vaccine was voluntary. They gave me muscles relaxer but it was messing with my heart. It took me until march till I was normal but I still have the fast blinking and lock in my mouth . I also had a seizure a month later.